The results presented lower expressions of PTEN and PLZF in high-grade prostate cancer specimens (GS = 8,9) than in mediate-grade (GS = 7) and well-differentiated (GS = 5,6) specimens. The gene discussed is PTEN; the disease is Familial prostate cancer.